This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Kuroiwa acquired his Ph.D. in molecular genetics from Tokyo Institute of Technology, Japan, studying genomic imprinting in mammals. Right after his
Ph.D. work, he joined KIRIN Brewery, CO. LTD., to develop its original chromosome engineering technology and contributed to generation of transgenic
mice producing human antibodies for human therapy. This achievement was highly recognized and he moved to US to join Hematech Inc to lead a project
of transgenic cattle producing human polyclonal antibodies to treat a wide variety of human diseases, as a Research Director of Molecular Genetics
department. He established an efficient genetic modification system in cattle and produced the world�s first transchromosomic and knockout cattle. As of
July 1st in 2009, he became a Chief Scientific Officer (CSO) of Research division in Hematech.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals